Marta Cano, PhD
Dr. Cano initiated her collaboration with the Laboratory for Neuropsychiatry and Neuromodulation at the Massachusetts General Hospital-Harvard Medical School during her predoctoral training in Electroconvulsive Therapy for Treatment-Resistant Depression and Magnetic Resonance Imaging. She is currently a postdoctoral researcher at Sant Pau Biomedical Research Institute, where she is leading the Neuroimaging Lab of the Sant Pau Mental Health Research Group. However, her close collaboration with Dr. Camprodon during the last years evolved her research line and she is primarily focused on understanding the dimensional impact of rapid-acting antidepressants on patients with treatment-resistant depression with the final aim to develop a personalized prediction model of antidepressant treatment response